|
|
On
September 30, 2004, the international prescription
drug company Merck announced the worldwide withdrawal
of the arthritis medication Rofecoxib, sold in
most countries under the brand name Vioxx, because
a study showed an increased risk of heart attack
and stroke. Patients who have suffered injuries
due to Vioxx have filed litigation against Merck
for failing to recall the drug when it first learned
of Vioxx's dangerous side effects.
To contact in confidence an experienced personal
injury attorney at Lieff Cabraser working on the
Vioxx lawsuit, click
here. |
|
|
|
|
|
The
painkiller Vioxx was marketed throughout the world,
sold in many countries under the name Vioxx and
in others as Ceoxx. Lieff Cabraser is working
with attorneys and solicitors in:
Argentina
Austria
Canada
Ireland
Italy
South Africa
United
Kingdom
and other countries to bring litigation against
Merck in U.S. courts for patients suffering heart
attacks and strokes from Vioxx. If you are visiting
this website from outside the U.S., please click
here to contact an attorney regarding your
experiences with Vioxx or Ceoxx. |
|
|
|
| |
|
|
|
|
|
Lieff
Cabraser Heimann & Bernstein, LLP
|
|
|
|
|
|
|
| Trademark
Notice |
| "Vioxx"
is a registered trademark of Merck. Lieff Cabraser Heimann
& Bernstein, LLP is in no way affiliated with Merck,
and the Vioxx trademark is used solely for informational
purposes. |
|
|
|
Copyright
© 2004-2005 Lieff Cabraser Heimann & Bernstein,
LLP
|
| |
|
|
"Medical
experts acknowledge that new pain killers pose dangers
but okay the drugs with stronger warnings"
Los Angeles Times, Feb. 19, 2005
A Food and Drug Administration advisory panel voted
Friday to let doctors prescribe Cox-2 painkillers,
including Bextra, Celebrex and Vioxx, but recommended
stronger warnings about the risk of heart attacks
and strokes. The advisory panel overwhelmingly agreed
that Cox-2 inhibitors all significantly increased
the risk of cardiovascular problems in patients.
The panel proposed that Celebrex, Vioxx and Bextra,
the third Cox-2 drug cleared by the FDA, carry "black
box" warnings -- the strongest admonishment
the FDA can give to doctors. Such warnings are likely
to discourage use of the drugs. Click
here to read more. |
|
|
|
|
|
| Lieff
Cabraser has participated in twenty-three $100 million-plus
settlements and verdicts. To read a summary, click
here. |
|
|
|
|
|

Click here to read
recent press articles on the Vioxx recall and Vioxx
lawsuits. |
|
|
|
|
|

Read about key events in the Vioxx recall and Vioxx
lawsuit by clicking here. |
|
|
|
|